- Home
- Test Categories
- Allergy Testing
- Autoimmune Diseases
- Blood and Blood Diseases
- Cancer Detection
- Diabetes
- DNA, Paternity and Genetic Testing
- Drug Screening
- Environmental Toxin Testing
- Female Specific Tests
- Fitness, Nutrition and Anti-Aging
- Gastrointestinal Diseases
- General Wellness
- Heart Health and Cholesterol
- Hormones and Metabolism
- Immunization Check
- Infectious Diseases
- Infertility Testing
- Kidney Diseases
- Liver Diseases
- Male Specific Tests
- Musculoskeletal Diseases
- Sexually Transmitted Diseases (STD's)
- Therapeutic Drug Monitoring
- Thyroid Diseases
- - STD Testing
- About STD Testing
- Chlamydia and Gonorrhea Test
- Cytomegalovirus (CMV) Antibodies, IgG
- Cytomegalovirus (CMV) Antibodies, IgM, Quantitative
- Epididymitis Screen
- Hepatitis A and B Immune Status Profile Test
- Hepatitis A and B Profile, Acute Diagnostic
- Hepatitis A and B Profile, Comprehensive
- Hepatitis A Antibody, IgM
- Hepatitis A Antibody, Total
- Hepatitis A Profile, Acute verses Chronic Differentiation
- Hepatitis B and C Profile Test (Comprehensive)
- Hepatitis B Core Antibody, IgG, IgM, Differentiation
- Hepatitis B Core Antibody, IgM
- Hepatitis B Core Antibody, Total
- Hepatitis B Patient Management Profile Test
- Hepatitis B Profile
- Hepatitis B Surface Antibody Test
- Hepatitis C Antibody Test
- Hepatitis C Virus (HCV) Antibody, With Reflex to RIBA
- Hepatitis C Virus (HCV), RNA PCR, Qualitative
- Hepatitis Panel, Acute
- Hepatitis Profile II (Diagnostic Follow-up)
- Herpes Simplex Virus (HSV) Type I and II IgG
- Herpes Simplex Virus (HSV) Type II IgG
- Herpes Simplex Virus (HSV), Type I and II IgM
- HIV-1 and HIV-2 Screen
- HIV-1 Antibodies Test
- HIV-1 DNA RT- PCR With HIV Antibodies , ICMA
- HIV-2 Antibodies
- HIV-2 Proviral DNA by PCR
- Human Immunodeficiency Virus 1 (HIV-1) RNA (bDNA)
- Mycoplasma/Ureaplasma, Real-Time PCR
- Soluble Liver Antigen (SLA) IgG Antibody (Autoimmune Hepatitis)
- STD Recent Exposure Panel
- STD Urinary Tract Infection Panel
- Syphilis (RPR) Test
- Treponema pallidum Antibodies (TP-PA)
- Ultimate STD Panel
- Ultimate Viral STD Panel
- See All STD Tests
- - Blood Tests
- Allergy Testing
- Autoimmune Disease Testing
- Blood Disorder and Blood Disease Testing
- Cancer Detection Testing
- Diabetes Testing
- DNA, Paternity and Genetic Testing
- Drug Screening Testing
- Environmental Testing
- Female-Specific Testing
- Fitness, Nutrition and Anti-Aging Testing
- Gastrointestinal Disease Testing
- General Wellness Testing
- Heart Health and Cholesterol Testing
- Hormone Blood Tests
- Immunization Testing
- Infectious Disease Testing
- Infertility Testing
- Kidney Disease Testing
- Liver Function Tests
- Musculoskeletal Disorders Testing
- Prostate Testing
- Therapeutic Drug Monitoring Testing
- Thyroid Testing
- - All Tests
- Lab Locations
- Why Online Lab Tests
- How it Works
- About Us
- FAQ
- Health Resources
Questions?
1.877.283.7882
1.877.283.7882
Private MD News
Home | News | ProstateProstate cancer research may encourage STD testing
Updated: 2009-09-09 22:26:27 CST Category: Prostate
by Brendan Missett
Oncologists may soon be able to more easily distinguish malignant cancers from benign or less serious growths, research suggests.
A report appearing in the Journal of the National Cancer Institute described research which indicated that a sexually transmitted parasite is likely to increase one's risk of developing prostate cancer, the U.S. News' HealthDay reports. Trichomonas vaginalis is an infection commonly screened for in women, but not men.
The study compared 673 men with prostate cancer with the same amount of healthy men. A statistically significant incidence of potentially deadly cancers was linked to men whose blood tests revealed them as hosts to the T. vaginalis infection.
Jennifer Rider Stark, lead researcher at the Harvard School of Public Health stressed that the types of cancer connected to the presence of the parasite were "either advanced at diagnosis or after follow-up proved to be fatal." She added that this study exposes the possibility of reducing the risk of life-threatening prostate cancer by screening for T. vaginalis.
According to estimates by the American Cancer Society, over 2 million men in the United States who have been diagnosed with prostate cancer are still alive, and approximately192,280 diagnoses of prostate cancer will be made in 2009.
Related Articles from Private MD:
-
Is HPV vaccine useful to males?
-
STD vaccinations in teens slow HPV spread
-
Weight gain may influence risk of prostate cancer
-
Promise of beer spreads word on prostate cancer testing
-
Pitchers Smoltz and Lowe aim to strike out prostate cancer
Subscribe to Private MD Health News RSS Feed: 
Visit the Health News Archive: Click Here
Questions about online blood testing or how to order a lab test? Click here to get started or call us toll-free at 1.877.283.7882. Our certified professionals are ready to assist you.
